Variant report

Variant	esv3431503
Chromosome Location	chr5:178015746-178018644
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:388)
CpG islands
(count:977)
Chromatin interactive
region (count:5)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:388 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr5:178016327-178016499	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr5:178016908-178018114	H1-hESC	embryonic stem cell:	n/a	n/a
3	BHLHE40	chr5:178017646-178018069	K562	blood:	n/a	n/a
4	BHLHE40	chr5:178017213-178017413	K562	blood:	n/a	n/a
5	CCNT2	chr5:178016854-178017709	K562	blood:	n/a	n/a
6	CEBPB	chr5:178017703-178018021	K562	blood:	n/a	chr5:178017711-178017728
7	CHD2	chr5:178017245-178017402	H1-hESC	embryonic stem cell:	n/a	n/a
8	CTBP2	chr5:178017016-178017975	H1-hESC	embryonic stem cell:	n/a	n/a
9	CTCF	chr5:178017340-178017490	SK-N-SH_RA	brain:	n/a	n/a
10	CTCF	chr5:178017740-178017890	BJ	skin:	n/a	n/a
11	CTCF	chr5:178017716-178017967	Pancreas_OC	pancreas:	n/a	n/a
12	CTCF	chr5:178017800-178017950	GM12865	blood:	n/a	n/a
13	CTCF	chr5:178018020-178018170	BJ	skin:	n/a	n/a
14	CTCF	chr5:178017364-178017370	NHEK	skin:	n/a	n/a
15	CTCF	chr5:178017709-178017959	Kidney_OC	kidney:	n/a	n/a
16	CTCF	chr5:178016920-178017070	AG04449	skin:	n/a	n/a
17	CTCF	chr5:178017900-178018050	NHEK	skin:	n/a	n/a
18	CTCF	chr5:178017760-178017910	AoAF	blood vessel:	n/a	n/a
19	CTCF	chr5:178017280-178017430	AG09319	gingival:	n/a	n/a
20	CTCF	chr5:178016920-178017070	Caco-2	colon:	n/a	n/a
21	CTCF	chr5:178017300-178017450	AoAF	blood vessel:	n/a	n/a
22	CTCF	chr5:178016949-178017107	GM12891	blood:	n/a	n/a
23	CTCF	chr5:178017687-178017871	A549	lung:	n/a	n/a
24	CTCF	chr5:178016902-178017117	H1-hESC	embryonic stem cell:	n/a	n/a
25	CTCF	chr5:178017580-178017594	H1-hESC	embryonic stem cell:	n/a	n/a
26	CTCF	chr5:178017635-178018001	K562	blood:	n/a	n/a
27	CTCF	chr5:178017957-178017971	GM10266	blood:	n/a	n/a
28	CTCF	chr5:178017118-178017121	H1-hESC	embryonic stem cell:	n/a	n/a
29	CTCF	chr5:178016938-178017106	SK-N-SH_RA	brain:	n/a	n/a
30	CTCF	chr5:178016940-178017090	NB4	blood:	n/a	n/a
31	CTCF	chr5:178017740-178017890	GM12867	blood:	n/a	n/a
32	CTCF	chr5:178017720-178017870	GM12801	blood:	n/a	n/a
33	CTCF	chr5:178017800-178017950	WI-38	lung:	n/a	n/a
34	CTCF	chr5:178016891-178017094	Lung_OC	lung:	n/a	n/a
35	CTCF	chr5:178016945-178017118	Fibrobl	skin:	n/a	n/a
36	CTCF	chr5:178017740-178017890	GM12878	blood:	n/a	n/a
37	CTCF	chr5:178017340-178017490	HPAF	blood vessel:	n/a	n/a
38	CTCF	chr5:178017703-178017943	HUVEC	blood vessel:	n/a	n/a
39	CTCF	chr5:178017780-178017930	Caco-2	colon:	n/a	n/a
40	CTCF	chr5:178016920-178017070	SK-N-SH_RA	brain:	n/a	n/a
41	CTCF	chr5:178016759-178017187	K562	blood:	n/a	n/a
42	CTCF	chr5:178016880-178017030	HA-sp	spinal cord:	n/a	n/a
43	CTCF	chr5:178017754-178017935	MCF-7	breast:	n/a	n/a
44	CTCF	chr5:178016857-178017410	K562	blood:	n/a	n/a
45	CTCF	chr5:178016910-178017167	LNCaP	prostate:	n/a	n/a
46	CTCF	chr5:178017300-178017450	K562	blood:	n/a	n/a
47	CTCF	chr5:178017720-178017870	HEK293	kidney:	n/a	n/a
48	CTCF	chr5:178017740-178017890	SAEC	small airway:	n/a	n/a
49	CTCF	chr5:178017807-178017894	Hela-S3	cervix:	n/a	n/a
50	CTCF	chr5:178017280-178017430	NHLF	lung:	n/a	n/a

(count:977 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:178017879-178017929	Caco-2	colon:	n/a
2	chr5:178017879-178017929	Caco-2	colon:	n/a
3	chr5:178017667-178017717	AG09319	gingival:	n/a
4	chr5:178017571-178017621	ProgFib	skin:	n/a
5	chr5:178017669-178017719	MCF-7	breast:	n/a
6	chr5:178017578-178017628	HNPCEpiC	eye:	n/a
7	chr5:178017937-178017987	AG04450	lung:	fetal
8	chr5:178017827-178017877	HepG2	liver:	n/a
9	chr5:178018015-178018065	HRE	kidney:	n/a
10	chr5:178017667-178017717	ProgFib	skin:	n/a
11	chr5:178016796-178016846	GM12891	blood:	n/a
12	chr5:178016195-178016245	HIPEpiC	eye:	n/a
13	chr5:178017853-178017903	Caco-2	colon:	n/a
14	chr5:178017853-178017903	GM06990	blood:	n/a
15	chr5:178017879-178017929	HCT-116	colon:	n/a
16	chr5:178017827-178017877	BJ	skin:	n/a
17	chr5:178016595-178016645	Hela-S3	cervix:	n/a
18	chr5:178017879-178017929	AG09319	gingival:	n/a
19	chr5:178018186-178018236	SK-N-MC	brain:	n/a
20	chr5:178016195-178016245	HNPCEpiC	eye:	n/a
21	chr5:178016796-178016846	H1-hESC	embryonic stem cell:	embryo
22	chr5:178017879-178017929	SAEC	small airway:	n/a
23	chr5:178017669-178017719	RPTEC	kidney:	n/a
24	chr5:178016195-178016245	SAEC	small airway:	n/a
25	chr5:178017853-178017903	H1-hESC	embryonic stem cell:	embryo
26	chr5:178017376-178017426	PrEC	prostate:	n/a
27	chr5:178017578-178017628	PFSK-1	brain:	n/a
28	chr5:178017300-178017350	H1-hESC	embryonic stem cell:	embryo
29	chr5:178017300-178017350	HRCEpiC	kidney:	n/a
30	chr5:178018015-178018065	HUVEC	blood vessel:	n/a
31	chr5:178017571-178017621	NHBE	bronchial:	n/a
32	chr5:178016595-178016645	NB4	blood:	n/a
33	chr5:178017667-178017717	MCF10A-Er-Src	breast:	n/a
34	chr5:178017376-178017426	HCPEpiC	choroid plexus:	n/a
35	chr5:178017578-178017628	HL-60	blood:	n/a
36	chr5:178016796-178016846	HRE	kidney:	n/a
37	chr5:178016796-178016846	SK-N-SH	brain:	n/a
38	chr5:178018015-178018065	HepG2	liver:	n/a
39	chr5:178017376-178017426	HIPEpiC	eye:	n/a
40	chr5:178017669-178017719	SK-N-SH_RA	brain:	n/a
41	chr5:178017667-178017717	Hela-S3	cervix:	n/a
42	chr5:178017937-178017987	HRE	kidney:	n/a
43	chr5:178016195-178016245	MCF10A-Er-Src	breast:	n/a
44	chr5:178018186-178018236	BE2_C	brain:	n/a
45	chr5:178017879-178017929	SK-N-MC	brain:	n/a
46	chr5:178017578-178017628	Hela-S3	cervix:	n/a
47	chr5:178017376-178017426	ProgFib	skin:	n/a
48	chr5:178017260-178017310	CMK	blood:	n/a
49	chr5:178016595-178016645	BJ	skin:	n/a
50	chr5:178017937-178017987	GM06990	blood:	n/a

(count:5 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr5:177631253..177632828-chr5:178016105..178018488,2	MCF-7	breast:
2	chr5:178015408..178017355-chr5:178028126..178029814,2	MCF-7	breast:
3	chr5:177659189..177660088-chr5:178017540..178018315,2	K562	blood:
4	chr5:178017942..178020045-chr5:178023632..178025333,2	K562	blood:
5	chr5:177887805..177889193-chr5:178016576..178017370,3	MCF-7	breast:

No data

Variant related genes	Relation type
COL23A1	TF binding region
COL23A1	CpG island
ENSG00000175309	chromatin interactions
ENSG00000197451	chromatin interactions

Extended variants
information (count: 95 )
Associated
traits (count: 101 )

Variant overlapped rSNPs/rCNVs (count:95 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs540502193	chr5:178015794-178015795	Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs573299677	chr5:178015810-178015811	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs262028	chr5:178015835-178015836	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs115965822	chr5:178015839-178015840	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs545103787	chr5:178015843-178015844	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs143257964	chr5:178015855-178015856	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs415043	chr5:178015911-178015912	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs455087	chr5:178015912-178015913	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs561314541	chr5:178015933-178015934	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs374713323	chr5:178015938-178015939	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs151106523	chr5:178015943-178015944	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs193161882	chr5:178015969-178015970	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs370301814	chr5:178015982-178015983	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs151249808	chr5:178016034-178016035	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs539194761	chr5:178016035-178016036	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs114748711	chr5:178016057-178016058	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs602019	chr5:178016091-178016092	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
18	rs370348826	chr5:178016128-178016129	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs536322351	chr5:178016152-178016153	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs554300228	chr5:178016180-178016181	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs184554667	chr5:178016197-178016198	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs577944808	chr5:178016205-178016206	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs553588600	chr5:178016207-178016208	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs262029	chr5:178016218-178016219	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
25	rs558386217	chr5:178016226-178016227	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs140690876	chr5:178016299-178016300	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs76631376	chr5:178016346-178016347	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs557452346	chr5:178016366-178016367	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs577184558	chr5:178016367-178016368	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs546891796	chr5:178016373-178016374	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs145908218	chr5:178016405-178016406	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs75312186	chr5:178016421-178016422	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs374298877	chr5:178016422-178016423	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs113439965	chr5:178016424-178016425	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs561167284	chr5:178016428-178016429	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs528483040	chr5:178016429-178016430	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs138390124	chr5:178016436-178016437	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs375768309	chr5:178016461-178016462	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
39	rs180735520	chr5:178016462-178016463	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
40	rs544950039	chr5:178016464-178016465	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
41	rs73804325	chr5:178016469-178016470	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs116496827	chr5:178016586-178016587	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs569416248	chr5:178016591-178016592	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs563143264	chr5:178016596-178016597	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs529789552	chr5:178016654-178016655	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs565168326	chr5:178016697-178016698	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs112115122	chr5:178016736-178016737	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs533508280	chr5:178016738-178016739	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs558444392	chr5:178016757-178016758	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs575645271	chr5:178016770-178016771	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:101)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Glioma	20126413	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
Thyroid cancer	19087340	CNVD
Acute myeloid leukemia	20729466	CNVD
lymphocytic leukemia	21291569	CNVD
Multiple myeloma	17550852	CNVD
Salivary gland tumor	18059337	CNVD
Renal cell carcinoma	19377443	CNVD
Lung cancer	18438408	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Renal cell carcinoma	18592004	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Prostate cancer	18632612	CNVD
epilepsy	18472482	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Sotos syndrome	21572526	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Sotos syndrome	17561922	CNVD
Sotos syndrome	16773131	CNVD
Mental retardation	16773131	CNVD
Sotos syndrome	22470819	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Acute myeloid leukemia	18000384	CNVD
Sudden cardiac death	19188705	CNVD
Basal cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Olfactory neuroblastoma	18408657	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
abnormal development	18461090	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Lung cancer	17297452	CNVD
Cancer	20164920	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21509527	CNVD
Breast cancer	21804112	CNVD
Myelofibrosis	22110671	CNVD
Sotos syndrome	22283845	CNVD
Breast cancer	16272173	CNVD
Sotos syndrome	20503325	CNVD
Lung adenocarcinoma	17086460	CNVD
Congenital Hypertrichosis Syndrome	21636067	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Breast cancer	19181860	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Ehlers-danlos syndrome	17576883	CNVD
Lung cancer	17086460	CNVD
Autism	19246517	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Breast cancer	21990379	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:475 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:178012800-178016600	Weak transcription	Right Atrium	heart
2	chr5:178012800-178016800	Weak transcription	Gastric	stomach
3	chr5:178013200-178016000	Weak transcription	Pancreas	Pancrea
4	chr5:178014200-178016600	Bivalent Enhancer	Fetal Heart	heart
5	chr5:178014400-178015800	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
6	chr5:178014600-178015800	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
7	chr5:178014600-178015800	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
8	chr5:178014600-178018000	Flanking Active TSS	Cortex derived primary cultured neurospheres	brain
9	chr5:178014800-178015800	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
10	chr5:178014800-178015800	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
11	chr5:178014800-178015800	Enhancers	Primary monocytes fromperipheralblood	blood
12	chr5:178014800-178015800	Bivalent Enhancer	Ganglion Eminence derived primary cultured neurospheres	brain
13	chr5:178014800-178016000	Bivalent Enhancer	Primary neutrophils fromperipheralblood	blood
14	chr5:178014800-178016200	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
15	chr5:178014800-178016600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
16	chr5:178015000-178015800	Weak transcription	H9 Cell Line	embryonic stem cell
17	chr5:178015000-178015800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
18	chr5:178015000-178015800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
19	chr5:178015000-178015800	Weak transcription	Right Ventricle	heart
20	chr5:178015000-178016000	Bivalent Enhancer	Fetal Stomach	stomach
21	chr5:178015000-178016600	Bivalent Enhancer	Fetal Muscle Leg	muscle
22	chr5:178015000-178016600	Enhancers	Left Ventricle	heart
23	chr5:178015200-178016400	Bivalent Enhancer	Stomach Smooth Muscle	stomach
24	chr5:178015400-178015800	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
25	chr5:178015600-178015800	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
26	chr5:178015600-178016600	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
27	chr5:178015600-178016800	Flanking Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
28	chr5:178015600-178017800	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
29	chr5:178015800-178016000	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
30	chr5:178015800-178016000	Bivalent Enhancer	H9 Cell Line	embryonic stem cell
31	chr5:178015800-178016000	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
32	chr5:178015800-178016000	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
33	chr5:178015800-178016000	Bivalent Enhancer	Brain Dorsolateral Prefrontal Cortex	brain
34	chr5:178015800-178016200	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
35	chr5:178015800-178016200	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
36	chr5:178015800-178016200	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
37	chr5:178015800-178016200	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
38	chr5:178015800-178016400	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
39	chr5:178015800-178016400	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
40	chr5:178015800-178016400	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
41	chr5:178015800-178016400	Bivalent/Poised TSS	Ganglion Eminence derived primary cultured neurospheres	brain
42	chr5:178015800-178016600	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
43	chr5:178015800-178016600	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
44	chr5:178015800-178016800	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
45	chr5:178015800-178016800	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
46	chr5:178015800-178016800	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
47	chr5:178015800-178017200	Bivalent/Poised TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
48	chr5:178015800-178017200	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
49	chr5:178015800-178017800	Flanking Active TSS	Right Ventricle	heart
50	chr5:178016000-178016200	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links